The Excellence in Oncology Care Conference (EIOC 2024) commenced today at the Intercontinental Festival City, Dubai, bringing together global oncology leaders to address the challenges in cancer care.
Running from October 11 to 12, the event offers a collaborative platform for knowledge-sharing and advancements in oncology.
With over 5,000 visitors, 200 expert speakers, and 30 specialised organisations participating, EIOC 2024 is poised to tackle the growing global cancer burden.
According to the World Health Organisation, cancer cases are projected to rise by over 75% by 2050, reaching more than 35 million new cases annually. The event seeks to address this by highlighting the latest advancements in oncology care, with 14 scientific sessions covering key areas such as breast cancer, lung cancer, immuno-oncology, and palliative care.
Dr. Abdulsalam AlMadani, Chairman of INDEX Holding, emphasized the UAE's role in advancing oncology, noting that EIOC provides a platform for local and international experts to collaborate, making it unnecessary for professionals to travel abroad for specialised conferences.
A key highlight of EIOC 2024 is the “Young Leaders in Oncology” initiative, which supports emerging professionals in the field. The programme, along with scientific workshops and discussions, fosters innovation and paves the way for new ideas in cancer treatment.
EIOC 2024 is organized by INDEX Conferences and Exhibitions in collaboration with key entities such as the Dubai Health Authority and the Oncology Nursing Society, reinforcing the UAE's position as a leading hub for medical education and innovation.
News Source: Emirates News Agency